



![SpectrumAi_logo-01[77560]](https://autismimpact.fund/wp-content/uploads/2022/06/SpectrumAi_logo-0177560-150x21.png)






Healios (US subsidiary: Meliora Health) is a multinational healthcare company providing telehealth
services for children and adults, online diagnosis for ADHD and autism, and mental health therapy. With
the highest standard in care delivery, Healios offers country-specific solutions in the UK and US markets.
Healios’ virtual-first ecosystem solution manages both the extensive range and the changing needs of
mild to complex MH and ND of children aged 18 months to 18 years, to deliver better care for individual
families. The virtual services include tech-driven diagnosis, mental health and client needs assessment,
and mental health support, with a suite of services including gold-standard diagnostic tools, goals-based
intervention, cognitive behavior therapy, professional coaching, and post-diagnostic support. Since its
inception, the company has completed 32K+ specialist patient referrals, 115K+ digital assessments, and
published 14 academic papers. Healios is referenced in NHS England’s National Autism Best Practice
Guide and has received two endorsements from the UK National Institution for Health and Care
Excellence (NICE). In the US, Meliora Health has coverage in 6 US states and are rolling out national
coverage in 2023.